Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Endocrinology|November 21, 2024
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityRyan J Jalleh, Chinmay S Marathe, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2024
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideRyan J Jalleh, Mark P Plummer, Chinmay S Marathe, et al.
Acta Diabetologica|December 19, 2019
The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose toleranceChinmay S Marathe, Hung Pham, Jessica A Marathe, et al.
Diabetes, Obesity & Metabolism|January 10, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetesKaren L Jones, Rachael S Rigda, Madeline D M Buttfield, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 29, 2014
Islet cell transplantation in Australia: screening, remote transplantation, and incretin hormone secretion in insulin independent patientsC S Marathe, C J Drogemuller, J A Marathe, et al.
Diabetes & Vascular Disease Research|December 13, 2016
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes|October 17, 2015
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled TrialSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
The Annals of Thoracic Surgery|January 1, 2020
Heterotaxy Is Not a Risk Factor for Adverse Long-Term Outcomes After Fontan CompletionSupreet P Marathe, Diana Zannino, Jacob Y Cao, et al.
Pageof 10